000 | 01982 a2200505 4500 | ||
---|---|---|---|
005 | 20250513161051.0 | ||
264 | 0 | _c19990311 | |
008 | 199903s 0 0 eng d | ||
022 | _a0305-1870 | ||
024 | 7 |
_a10.1111/j.1440-1681.1998.tb02172.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPiekarska, A E | |
245 | 0 | 0 |
_aKATP channel blocking actions of quaternary ions play no role in their antiproliferative action on mouse leukaemia and rat vascular smooth muscle cells in vitro. _h[electronic resource] |
260 |
_bClinical and experimental pharmacology & physiology _cDec 1998 |
||
300 |
_a992-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid _xpharmacology |
650 | 0 | 4 |
_aAdenosine Triphosphate _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aAorta _xcytology |
650 | 0 | 4 |
_aCell Division _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCisplatin _xpharmacology |
650 | 0 | 4 |
_aCoronary Vessels _xdrug effects |
650 | 0 | 4 |
_aDequalinium _xpharmacology |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aLeukemia L1210 _xpathology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xcytology |
650 | 0 | 4 |
_aOnium Compounds _xpharmacology |
650 | 0 | 4 |
_aOrganophosphorus Compounds _xpharmacology |
650 | 0 | 4 | _aPotassium Channel Blockers |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aRhodamine 123 _xpharmacology |
650 | 0 | 4 | _aSwine |
650 | 0 | 4 |
_aTetraphenylborate _xpharmacology |
650 | 0 | 4 |
_aVasoconstrictor Agents _xpharmacology |
700 | 1 | _aWebster, L | |
700 | 1 | _aSaltis, J | |
700 | 1 | _aMcPherson, G A | |
773 | 0 |
_tClinical and experimental pharmacology & physiology _gvol. 25 _gno. 12 _gp. 992-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1440-1681.1998.tb02172.x _zAvailable from publisher's website |
999 |
_c9849768 _d9849768 |